Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Conditions
- Acute Lymphocytic Leukemia
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Chronic Myelogenous Leukemia
Interventions
- DRUG: bortezomib
- DRUG: belinostat
- OTHER: laboratory biomarker analysis
- GENETIC: western blotting
- OTHER: pharmacological study
- OTHER: flow cytometry
Sponsor
Virginia Commonwealth University
Collaborators